ConductScience.org, home

Library / Genes

HCFC1: host cell factor C1

1 protein, 27 patents, 0 drugs, 0 trials, 3,546 NIH grants and 4,893 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolHCFC1HGNC
Namehost cell factor C1HGNC
NCBI Gene ID3054NCBI Gene
HGNC IDHGNC:4839HGNC
EnsemblENSG00000172534NCBI Gene
AliasesCFF, HCF, HCF-1, HCF1, HFC1, MAHCX, MGC70925, MRX3, PPP1R89, VCAF, XLID3NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P51610Host cell factor 12,03511Ensembl, GeneID, HGNCUniProt

Patents 27

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-2195P51610Espacenet
JP 2026004568 A2026-01-1449407P51610Espacenet
EP 4650780 A22025-11-194631P51610Espacenet
EP 4641201 A22025-10-294195P51610Espacenet
JP 2025517969 A2025-06-124195P51610Espacenet
JP 2025517970 A2025-06-124631P51610Espacenet
US 11860162 B22024-01-021329P51610Espacenet
JP 2023521663 A2023-05-2594P51610Espacenet
US 11446398 B22022-09-2038973P51610Espacenet
JP 2022524081 A2022-04-27141944P51610Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 3546

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P01CA013106Targeting Transcription and Splicing in Cancer372,025NIH's project files
P30CA008748Cancer Center Support Grant202,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program172,025NIH's project files
ZIAAI000712Transcriptional control of herpes simplex virus lytic infection and latency-reactivation cycles172,025NIH's project files
P30CA016672Cancer Center Support Grant142,025NIH's project files
P30EY001792P30 Core Grant for Vision Research142,025NIH's project files
P30CA014051Cancer Center Support (Core) Grant112,025NIH's project files
P30CA060553The Robert H. Lurie Comprehensive Cancer Center102,025NIH's project files
R01EY024710A new molecular therapy against ocular herpes102,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)92,025NIH's project files

Papers 4893

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42818113PubTator, text miningPubMed
42636713PubTator, text miningPubMed
42587014PubTator, text miningPubMed
42481616PubTator, text miningPubMed
42435717PubTator, text miningPubMed
42427522PubTator, text miningPubMed
42418427PubTator, text miningPubMed
42242496PubTator, text miningPubMed
42184340PubTator, text miningPubMed
42130149PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license